Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DLTR | COST |
|---|---|---|
| Price | $115.20 | $917.37 |
| Change today | ▲ 1.03% | ▲ 0.77% |
| Market cap | $21.62B | $406.64B |
| Return, 3 months | -4.9% | -0.6% |
| Return, year to date | -6.3% | +6.9% |
| Return, 1 year | +27.5% | +0.6% |
| P/E (TTM) | 14.2 | 44.2 |
| P/B | 6.3 | 11.4 |
| P/E percentile vs own 5y | 41st | 42nd |
| Dividend yield | – | 0.60% |
| Revenue growth (YoY, latest qtr) | +7.0% | +11.6% |
| Net profit growth (YoY) | +173.1% | +15.2% |
| Gross margin | 38.7% | 12.9% |
| Operating margin | 11.0% | 3.8% |
| Net margin | 8.0% | 3.0% |
| Return on equity | 45.9% | 29.2% |
| Analyst target vs. price | +20.6% | +18.4% |
| Analyst buy share | 50% | 72% |
| RSI (14) | 40 | 46 |
| 30-day volatility | 39.0% | 19.5% |
| Max drawdown, 1 year | -38.5% | -18.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
